LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

Home・Aktien・Avalo Therapeutics

A
Avalo Therapeutics

Geschlossen

10.08 3.92

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

9.42

Max

10.11

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+240.14 upside

Avalo Therapeutics Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

17. Okt. 2024, 23:57 UTC

Heiße Aktien

Stocks to Watch: Netflix, MGP Ingredients, Bausch Health

17. Okt. 2024, 22:35 UTC

Akquisitionen, Fusionen, Übernahmen

SLB to Sell Interest in Palliser Block in Canada

17. Okt. 2024, 21:33 UTC

Ergebnisse

Wichtige Markttreiber

Intuitive Surgical Shares Rise 6% After 3Q Earnings, Revenue Beat

17. Okt. 2024, 20:56 UTC

Ergebnisse

Intuitive Surgical Posts 3Q Revenue Growth

17. Okt. 2024, 23:51 UTC

Market Talk

BHP Unlikely to Quickly Approach Anglo American Again, Says Bull -- Market Talk

17. Okt. 2024, 23:22 UTC

Top News

Amex Earnings Will Test Stock's Rally. Revenue Is the Focus. -- Barrons.com

17. Okt. 2024, 23:14 UTC

Top News

Ergebnisse

Netflix Subscriber Growth Slows Amid Revenue Gains -- 4th Update

17. Okt. 2024, 22:56 UTC

Market Talk

Santos's Balance Sheet Risks to Ease From Here -- Market Talk

17. Okt. 2024, 22:52 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Santos's Upcoming Investor Day Likely Positive -- Market Talk

17. Okt. 2024, 22:32 UTC

Market Talk

De Grey Runs Into Delay on Hemi Permitting, But Approval Likely -- Market Talk

17. Okt. 2024, 22:23 UTC

Market Talk

Nike Outlook Revised on Unclear Outcome of Turnaround Strategy -- Market Talk

17. Okt. 2024, 22:13 UTC

Market Talk

Ergebnisse

Global Equities Roundup: Market Talk

17. Okt. 2024, 22:13 UTC

Market Talk

Ergebnisse

Netflix Isn't Interested in Bundling With Other Streaming Services -- Market Talk

17. Okt. 2024, 21:57 UTC

Top News

Ergebnisse

Netflix Subscriber Growth Slows Amid Revenue Gains -- 3rd Update

17. Okt. 2024, 21:48 UTC

Akquisitionen, Fusionen, Übernahmen

SLB: Palliser Block Consists of Oil and Gas Wells, Surface Facilities, a Pipeline Network and Certain Oil and Gas Development Rights >SLB

17. Okt. 2024, 21:48 UTC

Akquisitionen, Fusionen, Übernahmen

SLB: Transaction Is Expected to Close Late in the 4Q >SLB

17. Okt. 2024, 21:48 UTC

Akquisitionen, Fusionen, Übernahmen

SLB: Announces Definitive Agreement to Sell Its Interests in Palliser Block

17. Okt. 2024, 21:32 UTC

Market Talk

Ergebnisse

Netflix's Release Schedule Should be 'Largely Back to Normal' in 2025 -- Market Talk

17. Okt. 2024, 21:25 UTC

Top News

Google Executive Overseeing Search and Advertising Leaves Role -- 2nd Update

17. Okt. 2024, 21:21 UTC

Market Talk

Ergebnisse

Netflix Says It Will Double Revenue from Advertising in FY25 -- Market Talk

17. Okt. 2024, 21:18 UTC

Ergebnisse

Wichtige Markttreiber

Intuitive Surgical Shares Rise 6% After 3Q Earnings, Rev Beat

17. Okt. 2024, 21:10 UTC

Top News

Ergebnisse

Lucid Stock Tumbles 18%. EV Maker Plans Huge Share Sale, Sees Wider Losses. -- Barrons.com

17. Okt. 2024, 21:03 UTC

Akquisitionen, Fusionen, Übernahmen

CSX, Canadian Pacific Kansas City, Genesee & Wyoming: Surface Transportation Board Approves CSX, CPKC Respective Applications Regarding Acquisition of Rail Lines Operated by G&W's Meridian & Bigbee Railroad

17. Okt. 2024, 20:55 UTC

Ergebnisse

Netflix Clobbers Third-Quarter Estimates, Guides Above Views -- IBD

17. Okt. 2024, 20:55 UTC

Ergebnisse

Netflix Stock Jumps on a Strong Outlook for Profit Margin. Prices Are Going Up Across the World. -- Barrons.com

17. Okt. 2024, 20:50 UTC

Ergebnisse

Netflix Stock Jumps on a Strong Outlook for Profit Margin. Prices Are Growing Up Across the World. -- Barrons.com

17. Okt. 2024, 20:50 UTC

Market Talk

Ergebnisse

Auto & Transport Roundup: Market Talk

17. Okt. 2024, 20:50 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Tech, Media & Telecom Roundup: Market Talk

17. Okt. 2024, 20:50 UTC

Market Talk

Ergebnisse

Basic Materials Roundup: Market Talk

17. Okt. 2024, 20:49 UTC

Top News

Ergebnisse

Netflix Subscriber Growth Slows Amid Revenue Gains -- 2nd Update

Peer-Vergleich

Kursveränderung

Avalo Therapeutics Prognose

Kursziel

By TipRanks

240.14% Vorteil

12-Monats-Prognose

Durchschnitt 35 USD 240.14%

Hoch 35 USD

Tief 35 USD

Basierend auf 1 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Avalo Therapeutics – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

1 ratings

Buy

Halten

Sell

Basierend auf 1 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Avalo Therapeutics – Dist abgegeben haben.

Finanzen

Andere Aktien aus dem Sektor

LLY

Eli Lilly and Co.

916.07

↓-0.02%

UNH

UnitedHealth Group Inc

566.13

↓-0.87%

NVO

Novo Nordisk A-S

118.17

↑ +0.23%

JNJ

Johnson and Johnson

164.55

↑ +0.16%

ABBV

AbbVie Inc

188.57

↓-1%

A Avalo Therapeutics

Übersicht

Veränderung der Aktienkurses

Empfehlungen

Avalo Therapeutics Chart

Ähnliche Nachrichten

Peer-Vergleich

Avalo Therapeutics Prognose

Kursziel

Rating-Konsens

Finanzen

Andere Aktien aus dem Sektor

Crucial information about Facebook accounts

A
Avalo Therapeutics